iTeos Therapeutics, Inc. - stock earnings
ITOS Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -30.6 million USD | ? USD |
2023Q3 | -32.2 million USD | ? USD |
2023Q2 | -34.3 million USD | ? USD |
2023Q1 | -15.6 million USD | 12.6 million USD |
2022Q4 | 20.5 million USD | 53.9 million USD |
2022Q3 | 991000 USD | 19.5 million USD |
2022Q2 | 5.6 million USD | 41.7 million USD |
2022Q1 | 69.6 million USD | 152.5 million USD |
2021Q4 | 184.9 million USD | 240.5 million USD |
2021Q3 | 69.6 million USD | 104.3 million USD |
2021Q2 | -26.5 million USD | ? USD |
2021Q1 | -13.5 million USD | ? USD |
2020Q4 | -14.9 million USD | ? USD |
2020Q3 | -10.7 million USD | ? USD |
2020Q2 | -7.2 million USD | ? USD |
2020Q1 | -5.2 million USD | ? USD |
2019Q4 | -5.4 million USD | ? USD |
2019Q3 | -6.9 million USD | ? USD |
2019Q2 | -5.8 million USD | ? USD |
2019Q1 | -4.4 million USD | ? USD |
ITOS Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -112.6 million USD | 12.6 million USD |
2022 | 96.7 million USD | 267.6 million USD |
2021 | 214.5 million USD | 344.8 million USD |
2020 | -38.0 million USD | ? USD |
2019 | -22.5 million USD | ? USD |
2018 | -18.1 million USD | ? USD |
ITOS
Price: $11.66
52 week price:
Earnings Per Share: -3.15 USD
P/E Ratio: -5.75
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 231111
Market Capitalization: 397.9 million